WordNet

resulting from or employing derivation; "a derivative process"; "a highly derivative prose style"
a compound obtained from, or regarded as derived from, another compound
(linguistics) a word that is derived from another word; "`electricity is a derivative of `electric"
antidiabetic consisting of any of several drugs that reduce the level of glucose in the blood; used to treat diabetes mellitus
of or relating to hypoglycemia; "hypoglycemic agents" (同)hypoglycaemic

PrepTutorEJDIC

《所有・所属》…『の』,…のものである,…に属する・《材料・要素》…『でできた』,から成る・《部分》…『の』[『中の』] ・《数量・単位・種類を表す名詞に付いて》…の・《原因・動機》…『で』,のために(because of) ・《主格関係》…『の』,による,によって・《目的格関係》…『を』,の・《同格関係》…『という』・《関係・関連》…『についての』[『の』],の点で・《抽象名詞などと共に》…の[性質をもつ] ・《『It is』+『形』+『of』+『名』+『to』 doの形で,ofの後の名詞を意味上の主語として》・《分離》…『から』・《起原・出所》…『から』[『の』](out of) ・《『名』+『of』+『a』(『an』)+『名』の形で》…のような・《『名』+『of』+『mine』(『yours, his』など独立所有格)の形で》…の…・《時》(1)《副詞句を作って》…に《形容詞句を作って》…の・《時刻》《米》…前(to,《米》before)
派生した,由来した;独創性のない,借り物めいた / 派生語 / 派生した物

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. 糖尿病の治療におけるスルホニル尿素およびメグリチニド sulfonylureas and meglitinides in the treatment of diabetes mellitus
2. 幼児および小児における低血糖症の病因 etiology of hypoglycemia in infants and children
3. スルホニル尿素剤中毒 sulfonylurea agent poisoning
4. 2型糖尿病における持続性高血糖のマネージメント management of persistent hyperglycemia in type 2 diabetes mellitus
5. 糖尿病を有する成人における血糖の周術期マネージメント perioperative management of blood glucose in adults with diabetes mellitus

Type 2 Diabetes Mellitus Treatment Patterns Across Europe: A Population-based Multi-database Study.

Overbeek JA1, Heintjes EM2, Prieto-Alhambra D3, Blin P4, Lassalle R4, Hall GC5, Lapi F6, Bianchini E6, Hammar N7, Bezemer ID2, Herings RMC8.
Clinical therapeutics.Clin Ther.2017 Apr;39(4):759-770. doi: 10.1016/j.clinthera.2017.02.008. Epub 2017 Mar 23.
PMID 28342563

Differential cardiovascular outcomes after dipeptidyl peptidase-4 inhibitor, sulfonylurea, and pioglitazone therapy, all in combination with metformin, for type 2 diabetes: a population-based cohort study.

Seong JM1, Choi NK2, Shin JY3, Chang Y4, Kim YJ5, Lee J6, Kim JY7, Park BJ8.
PloS one.PLoS One.2015 May 20;10(5):e0124287. doi: 10.1371/journal.pone.0124287. eCollection 2015.
PMID 25992614

An advanced microencapsulated system: a platform for optimized oral delivery of antidiabetic drug-bile acid formulations.

Mooranian A1, Negrulj R, Mathavan S, Martinez J, Sciarretta J, Chen-Tan N, Mukkur TK, Mikov M, Lalic-Popovic M, Stojancevic M, Golocorbin-Kon S, Al-Salami H.
Pharmaceutical development and technology.Pharm Dev Technol.2015;20(6):702-9. doi: 10.3109/10837450.2014.915570. Epub 2014 May 5.
PMID 24798888